A good trail result offset by a poor Trail design and implementation.
They knew the scar are +12 years old but still went ahead, and only 3 months.
If they enrolled younger scars for 3 more months the result would be fantastic.
A big thumb up for the drug but a thumb down for Gary's skill of management and Quality Control, PXS is too small to waste time and fund like this.
Much younger scars for 6 months will definitely see the trail with huge success. the share price should be 10 times more than it is now.
Ann: PXS Announces Encouraging Results from Phase 1c Scar Study, page-16
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.5¢ |
Change
0.003(13.6%) |
Mkt cap ! $29.85M | |||
| Open | High | Low | Value | Volume |
| 2.5¢ | 2.5¢ | 2.2¢ | $133.0K | 5.414M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 150000 | 2.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.5¢ | 252707 | 2 |
View Market Depth
| Last trade - 16.10pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
2.5¢ |
Change
0.003 ( 19.1 %) |
||||
| Open | High | Low | Volume | ||
| 2.4¢ | 2.5¢ | 2.2¢ | 805569 | ||
| Last updated 15.56pm 07/06/2024 ? | |||||
| SNT (ASX) Chart |